News
21.05.2020

REGISTER NOW! Webinar: Your Trial Post-COVID: Recovery Must Start Now, Friday, 29 May 2020

Cromos Pharma, in association with MKR Clinical Research Consultants, presents a webinar: 

Your Trial Post-COVID: Recovery Must Start Now 

Friday, 29 May 2020

(9am PST, 12pm EST, 6pm CET)

REGISTER NOW

Join our experts for a forward-looking webinar focused on getting your clinical trials back on track as many countries begin to lift COVID-19 pandemic restrictions. By using scenario-based modelling our team has developed a comprehensive roadmap for restarting clinical trials as we move into a new phase of dealing with the pandemic.

Webinar Overview

The COVID-19 pandemic has had a significant impact on the clinical trial industry with many trials halted, others postponed while for those ongoing there has been a shift to remote and virtual communications with trial sites. There is growing recognition that we will be dealing with this pandemic for some time and that its effects will be far reaching, changing the ways in which clinical research has been traditionally conducted. In the light of this, it is imperative that we consider what actions are needed to resume clinical trials amid these new conditions. 

Cromos Pharma has approached this challenging task by taking an ongoing international trial and subjecting it to extensive risk assessment and scenario-based modeling. The trial metrics were analysed based on different actions, from waiting for the return of business as usual to the most aggressive rescue measures available. 

After studying the outcomes our expert team has come up with a comprehensive roadmap to navigate the “new normal” and get clinical trials up and running in the most effective and efficient manner possible.

Join us to see the range of actions required to ensure preparedness for restarting clinical trials as the pandemic enters a more controlled phase. Register now!

 Speakers 

Vlad.png 

 

Vlad Bogin, MD, FACP 

CEO & Founder @Cromos Pharma

Dr. Bogin started his medical training at Moscow Medical Academy, then trained at Yale and Brown Universities and received his postgraduate training at the University of Rochester where he was also elected to a chief medical resident position. Dr. Bogin has been involved in the drug development cycle for over 15 years, from basic discovery research to clinical trial design and execution. As a director at Boehringer Ingelheim he was in charge of late stage development of a leading cardiology product. As the Chairman of the Board at Medistem Inc., Dr. Bogin was instrumental in advancing the company from the preclinical to clinical stage, from a non-reporting to a fully reporting publicly trading company, and for a subsequent successful liquidity event in early 2014. Dr. Bogin maintains active medical license and hospital privileges and is an advisor to numerous companies and non-profit organizations. Dr. Bogin is an author of numerous peer-reviewed articles, book chapters and patents. 

Steph.png   

Stephanie Finnegan, MBA 

COO @Cromos Pharma 

Stephanie Finnegan is the Chief Operating Officer of Cromos Pharma, and is responsible for global operations, spanning North America, Europe, and Asia. She has thirty years of experience in pharmaceutical drug development, ranging from M&A and portfolio management to biomanufacturing and clinical research. She founded the biotech industry’s first contract manufacturer specializing strictly in recombinant proteins and monoclonal antibodies. For the past fifteen years, she has been working as a leader in CRO organizations, using her broad experience to specialize in biologics, biosimilars, and oncology/immunology. Stephanie has a BS in mathematics and an MBA/CPA.

Photo.png 

Jason Rubine, MSH 

Director of Clinical Operations @MKR Clinical Research Consultants

Jason Rubine is a clinical research professional with 15+ years of industry experience at the Sponsor and CRO levels across numerous therapeutic areas. With his combined scientific and research knowledge, he understands the most intricate details of the research industry in order to bring the clinical trials to success. Mr. Rubine heads up a geographically dispersed team and contributes heavily toward MKRs operational excellence. In addition, Mr. Rubine provides a lead role in client management, working with client managers and vendors within the industry to meet their needs for staffing solutions. Jason has a bachelor’s degree in Nutritional Science from The Pennsylvania State University and a master’s degree in Nutritional Science from The University of North Florida.  

Vladimir.png   

Vladimir Krechikov, MD, PhD 

Head of Region, Eastern Europe @Cromos Pharma

Dr Vladimir Krechikov started his career in clinical research as an investigator, then worked at various positions in clinical operations of global CROs before transitioning to a Director of Business Development position at one of the largest regional CROs. More than 10 years ago, Dr. Krechikov moved to Cromos Pharma, where he held various positions in Business Development and is now Head of Region, Eastern Europe. He graduated from Smolensk State Medical Academy (Russia) as a medical doctor, then received his postgraduate training at Queen Mary University of London (UK) and received PhD in clinical pharmacology. He is an author of more than 30 scientific publications in peer-reviewed journals.

Zsolt.png   

Zsolt Kocsis, MD, MBA

Country Head, Hungary @Cromos Pharma

Zsolt Kocsis is a clinical research professional with 12+ years of industry experience at sponsor and CRO levels across numerous therapeutic areas. Dr. Kocsis heads the Hungarian Office of Cromos Pharma and contributes to Cromos Pharma’s Central European operations. Zsolt holds a medical degree (MD) and a business degree (MBA). 

 

 

 

Other News:
news

First patients enrolled in international ST-Elevation Myocardial Infarction trial

Cromos Pharma is pleased to share news about our latest project - an international double-blind placebo-controlled clinical trial of RPH-104 in acute ST-Elevation Myocardial Infarction (STEMI). The trial involving patients in the US and in Russia will investigate how a biologic RPH-104 developed by R-Pharm can reduce an acute inflammatory response after myocardial infarction and lead to improved outcomes for STEMI patients.

29.04.2021
news

EU drug and device legislation: What you need to know

After a year-long delay due to the COVID-19 pandemic, the EU Medical Devices Regulation (EU MDR) is set to come into effect on May 26th 2021. Regulation 2017/746 on In-Vitro Diagnostic Devices (IVDR) will come into effect May 2022 after a five year transition period. Find out what you need to know about these regulations.
28.04.2021
news

eCONSENT and clinical trials

Clinical research is possible because patient volunteers give their consent to participate in trials. Informed consent is a key part of enrolling patients in a clinical trial whereby the potential participant receives all the information they need about their role in the clinical trial. This article considers the trend towards eCONSENT.
22.04.2021
news

Decentralization and remote monitoring during COVID-19

Cromos Pharma's Vladimir Krechikov, Head of Region, Eastern Europe and CIS and Maria Zaytseva, Head of Quality Assurance will present at the VIII All-Russian conference with international participation "Topical issues of preclinical and clinical trials of drugs, biomedical cell products and clinical trials of medical devices", St. Petersburg, April 22-23, 2021.

19.04.2021
news

Reasons why Georgia needs to be on your list of locations for clinical trials

With its rapid regulatory approval process, significant naïve populations in a range of therapeutic areas, skilled medical personnel and a conducive economic environment for doing business Georgia is regarded as a hidden gem for those interested in initiating novel studies and rescue trials. 
06.04.2021
news

Simple Math for Clinical Trial Success

Today we launched a brand new video Simple Math with Cromos Pharma showing you how we can help ensure your clinical trial's success. 
31.03.2021
news

Colorectal Cancer: A survivor's story

Throughout March we have been highlighting colorectal cancer, the amazing teams of researchers who are continuously fighting this disease, as well as the millions of patients and families who have been deeply affected by this silent killer. To close out this month of awareness-raising we want to introduce you to a real-life hero and colon cancer survivor - Arlene.

30.03.2021
news

Colorectal Cancer Awareness Month

March is Colorectal Cancer Awareness Month. Colorectal cancer (CRC) is the third most common and second most deadly cancer worldwide according to 2020 figures from the Global Cancer Observatory. 

25.03.2021
news

Data management and Biostatistics solutions to ensure the quality of your data

Effective data management and biostatistics are crucial for producing high quality data for successful clinical trials. At Cromos Pharma our expert data management and biostatistics team provides innovative solutions to ensure transparency, data integrity and quality of your data.
23.03.2021
news

Cromos Pharma appoints new Business Development Director for Central and Eastern Europe

At Cromos Pharma we are constantly growing and developing expanding our horizons and building our capacity to deliver innovative clinical trials solutions across our global network of operations. Therefore, we are delighted to announce the appointment of Nataliya Artyushenko as our new Business Development Director for Central and Eastern Europe.
21.03.2021
news

Reasons to choose Ukraine as the location for your next clinical trial

Ukraine, the eight largest European country by population, is an attractive location for sponsors conducting clinical research for a number of key reasons. Cromos Pharma has been successfully managing clinical trials in Ukraine since 2006. This article looks at just some of the benefits of locating your next study here.

16.03.2021
news

Cromos Pharma charting new territories as it looks east to Uzbekistan

Cromos Pharma is continuously developing and looking to explore new territories when it comes to clinical research. In line with this spirit of discovery, we will be shortly commencing a new project in Uzbekistan supporting a study being conducted by the Swiss Tropical and Public Health Institute. 

11.03.2021
news

IWD2021: Championing Women making healthcare breakthroughs

March 8th is International Women’s day, a global day of celebration of the social, political cultural and economic achievements of women. It is also a day for promoting the goal of greater gender parity across all sections of society. At Cromos Pharma, we are using this day to celebrate just a few of the many trailblazing women in healthcare.
08.03.2021
news

Cromos CEO outlines advantages of Central and Eastern Europe for clinical trials

Thinking about Eastern Europe as a venue for your clinical trial? Cromos Pharma CEO Vlad Bogin outlines some of the advantages in this new interview.
04.03.2021
news

Rare diseases and drug development

The World Economic Forum estimates that 475 million people worldwide are affected by a rare disease. To mark World Rare Disease Day (28 February 2021), in this article Stephanie Finnegan, Cromos Pharma’s COO, explores the opportunities and challenges for rare disease drug development.
26.02.2021
news

Key factors to consider for rare disease/orphan drug development

To mark World Rare Disease Day (28th February 2021), Cromos Pharma's Head of Start-Up outlines some of the key factors to consider for rare disease/orphan drug clinical trials.
26.02.2021
news

Connect with us at DIA Europe and BIO-Europe this March

Cromos Pharma is delighted to be taking part in the upcoming DIA Europe conference (15 – 19 March 2021) and BIO-Europe Spring (22-25 March 2021).

 

15.02.2021
news

International Women and Girls in Science Day

February 11th is International Women and Girls in Science Day. A joint UNESCO and UN-Women initiative, it aims to promote the role of #WomenInScience and to challenge some of the barriers to girls pursuing a career in science.

11.02.2021
news

Top 5 reasons to locate your next clinical trial in Hungary

Discover some of the reasons why you should consider Hungary as a location for your next clinical trial.
09.02.2021
news

Cromos Pharma offers EU Legal Representative Service

Are you a sponsor seeking to conduct clinical trials in the European Union but do not have a registered office in the European Economic AreaIf so, in order to comply with the European Union Clinical Trial Directive, you are required to work with a Legal Representative registered in an EEA country.

04.02.2021
news

World Cancer Day 2021: Cromos Pharma is committed to supporting clinical research to make cancer breakthroughs

Each 4th February, #WorldCancerDay aims to raise awareness of the global personal, social and economic burden of cancer. World Cancer Day was established in Paris at the first World Cancer Summit in 2000.

 


04.02.2021
news

European Medicines Agency: Approvals January 2021

The European Medicines Agency (EMA)’s Committee for Medicinal Products for Human Use (CHMP) recommended 13 new medications for approval and three therapeutic indication extensions in its January 2021 meeting.
31.01.2021
news

Upcoming EU drug/device legislation: What you need to know

Zsolt Kocsis, Cromos Pharma's Head of EU Operations explores some of the upcoming changes to EU legislation in relation to drug development and medical devices. 
25.01.2021
news

Reaping the benefits of a Euro-Australian collaboration for biotechs: save on costs and time

Cromos Pharma CEO Dr Vlad Bogin is joined by Avance Clinical's CEO Yvonne Lungershausen to discuss some of the benefits available to biotechs by availing of a joint initiative that combines Australian tax benefits for clinical research with exceptional patient recruitment and retention in Eastern European markets.
24.01.2021
news

Clinical trials in the time of COVID: Risks, mitigation and lessons learned

Clinical trials in the time of COVID: Risks, mitigation and lessons learned presented by Stephanie Finnegan, COO Cromos PharmaIn this presentation she looks at risks, how to mitigate crisis management, and what the sector has learned since being forced into some major changes due to COVID-19. 

24.01.2021
news

Clinical trials: how to enroll on time, stay on budget and not compromise data quality

Stephanie Finnegan, COO of Cromos Pharma delivers key insights into how to maintain study and data integrity when facing cost and time constraints. When time and money is of the essence how can you achieve patient recruitment targets? 
23.01.2021
news

Global vaccine rollout underway as COVID-19 cases surge

As 2021 begins, many countries are grappling with a renewed surge of COVID-19 infections necessitating further public health restrictions putting more pressure on health systems, societies and global economies.  The task of rolling out approved vaccines is increasingly urgent. Almost 16 million doses of COVID-19 vaccines have been administered to date in 37 countries worldwide according to data compiled by Bloomberg ( updated 7 Jan 2021). 

07.01.2021
news

JP Morgan Healthcare Conference: Virtual Booth and Daily Presentations

We have been meeting you at the JP Morgan Healthcare Conference for the past 11 years and there is no way we are going to break with this tradition. Meet us at the CROMOS PHARMA VIRTUAL BOOTH January 11th through 14th from 8 am to 5 pm(PST). Learn about some of the most vital issues in clinical research by attending our daily presentations or stop by anytime for a chat.


01.01.2021
news

Seasons Greetings from Cromos Pharma

Seasons Greetings from everyone at Cromos Pharma. Watch our holiday video here>>
22.12.2020
news

Watch: The benefits of Cromos Pharma and Avance Clinical's biotech initiative

In October we launched an exciting collaboration with Avance Clinical to offer biotechs a scalable clinical trials solution. The collaboration allows biotechs to quickly start their pre-IND early phase studies in Australia, then expand to Central/Eastern Europe to access the large patient populations for their Phase 2 and 3 studies. In this new video you can learn more about the benefits of this initiative.


08.12.2020
news

World AIDS Day 2020: Remarkable progress but the fight continues

Tuesday 1 December marked World AIDS Day 2020. Although throughout this year our focus has been on the coronavirus pandemic, World AIDS Day is an opportunity to reflect on another pandemic where a virus passed from animals to humans with devastating consequences. To date 77 million people worldwide have been infected with HIV. In spite of innovative new treatments 35 million people have died from the virus. 

01.12.2020
news

Thanksgiving Greetings

Thanksgiving Greetings from everyone at Cromos Pharma. Watch our video here.
20.11.2020
news

World Pancreatic Cancer Awareness Day 2020

Thursday 19 November 2020 is World Pancreatic Cancer Awareness Day. Here at Cromos Pharma we are proud to play our part in supporting clinical trials aimed at finding better treatments for pancreatic cancers. 

19.11.2020
news

FDA Offers Guidance to Enhance Diversity in Clinical Trials

The FDA released a statement (9 November 2020) outlining its commitment to promoting greater diversity in medical product development and issuing a new guidance document outlining the agency's thinking on encouraging greater inclusivity “Enhancing the Diversity of Clinical Trial Populations--Eligibility Criteria, Enrollment Practices, and Trial Designs,”
12.11.2020
news

Cromos Pharma and Avance Clinical share details of innovative collaboration at BIO-Europe 2020

Cromos Pharma and Avance Clinical announced details of their innovative collaboration to offer biotechs scalable clinical trial solutions at BIO-Europe 2020.
28.10.2020
news

Orphan Drugs Market to Reach USD 340.84 Billion by 2027

The global orphan drugs market size is projected to reach USD 340.84 billion by the end of 2027. Increasing number of regulatory approvals will have a positive impact on the growth of the overall market in the coming years according to a new report from Fortune Business Insights
26.10.2020
news

Cromos Pharma and Avance Clinical launch scalable clinical trial solution for biotech

Cromos Pharma is delighted to announce a new collaboration with Avance Clinical providing a scalable clinical trial solution for biotech.
08.10.2020
news

Video: Cromos Pharma and Avance Clinical Collaboration

Cromos Pharma and Avance Clinical are joining forces to offer a scalable clinical trial solution for biotechs. Watch the video to find out more>>
08.10.2020
news

Alzheimer's Awareness Month: Q&A with Dr Sabina Brennan

September is World Alzheimer’s Month. Alzheimer’s Disease (AD) is the most well-known form of dementia. Dementia is the collective name for progressive brain conditions affecting memory, thinking, behavior and emotions. Dementia affects almost 50 million people worldwide. While aging is a major risk factor for dementia, it also affects people under 65 years. To mark Alzheimer’s Awareness Month (Sept 2020) we sat down with leading psychologist, neuroscientist and best-selling author Dr Sabina Brennan. Dr Brennan is a brain health expert who has advised Irish and UK governments on policies relating to aging and dementia.  She is the Irish national representative on the Medical and Scientific Advisory Panel for Alzheimer’s Disease International.
28.09.2020
news

Watch Webinar: Where in the world should I locate my pivotal clinical trial?

If you missed the live webinar “Where in the world should I locate my pivotal clinical trial?” you can now watch the recording by clicking hereThe webinar hosted by the Society of Physician Entrepreneurs (SoPE) and Workforce Genetics features Cromos Pharma's CEO Vlad Bogin, M.D, FACP. 


24.09.2020